Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
The U.S. FDA grants orphan drug designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for treatment of endogenous Cushing's syndrome
11 Sep 2026
PR Newswire Association LLC.
Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
10 Sep 2026
PR Newswire Association LLC.
BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
10 Sep 2026
PR Newswire Association LLC.
EMPE Diagnostics to Unveil CircuLOK Product Range at NATCON 2026, Expanding Access to TB Drug-Resistance Diagnostics
10 Sep 2026
PR Newswire Association LLC.
Denmark's new Region Østdanmark expands with Sectra to unify imaging region-wide
10 Sep 2026
PR Newswire Association LLC.
Qedma and HQC2 Demonstrate Unprecedented Accuracy in Quantum Chemistry on Quantum Computers
09 Sep 2026
PR Newswire Association LLC.
BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health
09 Sep 2026
PR Newswire Association LLC.
SciBase receives additional order from Castle Biosciences, advancing the collaboration
08 Sep 2026
PR Newswire Association LLC.
Norlase Expands European Footprint with Direct Commercial Presence in the United Kingdom
08 Sep 2026
PR Newswire Association LLC.
Epicyt Pharma reports positive results in first-in-human study of BAFA in patients following gastric bypass surgery
08 Sep 2026
PR Newswire Association LLC.
Novonesis to build next generation enzyme production facility in India
04 Sep 2026
PR Newswire Association LLC.
Orbis Flying Eye Hospital Marks 20 Years of Partnership with Macau
04 Sep 2026
PR Newswire Association LLC.
Sectra's three-month interim report: Growing cloud recurring revenue
04 Sep 2026
PR Newswire Association LLC.
SCIBASE RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 58 MILLION
03 Sep 2026
GlobeNewswire
ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report
07 Aug 2026
GlobeNewswire
Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years
07 Aug 2026
GlobeNewswire
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
06 Aug 2026
GlobeNewswire
Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026
06 Aug 2026
GlobeNewswire
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
06 Aug 2026
GlobeNewswire
Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition
06 Aug 2026
GlobeNewswire
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
06 Aug 2026
GlobeNewswire
Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S.
06 Aug 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Market launch of the nasal adrenaline spray, neffy®, for treatment of adults and children with severe allergies in Canada
05 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
Latest News All News
Upcoming Events All Events
- September 2026
- Rockville: BioHealth Capital Region Forum & Investment Conference
- Seoul: Korea Life Science Week
- Boston: RESI Boston 2026